Daniel Loeb - Third Point
Holding/activity history for ARS Pharmaceuticals, Inc. (SPRY)
← All SPRY superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,000,000 | 0.39 | Add 79.78% | 0.17 | $7.20–13.15 · VW $9.73i | $8,030,000 | SEC |
| 2025 Q4 | 556,237 | 0.09 | Buy | 0.09 | $6.66–11.99 · VW $9.58i | $6,480,161 | SEC |
Price snapshot:
Current price$7.74
Avg. buy price$10.04
+/- since buy-22.94%
52-week low$6.66
52-week high$18.63